| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/05/2013 | US8367826 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/05/2013 | US8367698 3-substituted sulfonyl piperidine derivative |
| 02/05/2013 | US8367694 Carboline derivatives useful in the inhibition of angiogenesis |
| 02/05/2013 | US8367692 Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 tachikynin receptor antagonists |
| 02/05/2013 | US8367691 Modulators of muscarinic receptors |
| 02/05/2013 | US8367662 Organic compounds |
| 02/05/2013 | US8367224 Organic electroluminescence element, new compound for the same, display device and lighting device using the same |
| 02/05/2013 | US8366792 Dye composition comprising a heterocyclic oxidation base and an indole coupler |
| 02/05/2013 | CA2589127C 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 02/05/2013 | CA2558899C Fused ring azadecalin glucocorticoid receptor modulators |
| 02/05/2013 | CA2511340C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 02/05/2013 | CA2508792C Heterocyclic compounds, methods of making them and their use in therapy |
| 01/31/2013 | WO2013016488A1 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 01/31/2013 | WO2013016197A1 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators |
| 01/31/2013 | WO2013015984A1 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | WO2013014567A1 Indazoles |
| 01/31/2013 | WO2013014448A1 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer |
| 01/31/2013 | WO2013014060A1 Substituted quinolines and their use as medicaments |
| 01/31/2013 | WO2013013816A1 Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/31/2013 | WO2012143416A3 7 - (3,5 - dimethyl - 4 - isoxazolyl) - 8 - (methyloxy) - 1h - imidazo [4,5 -c] quinoline derivatives |
| 01/31/2013 | US20130030181 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
| 01/31/2013 | US20130030178 Methods of making hiv attachment inhibitor prodrug compound and intermediates |
| 01/31/2013 | US20130030174 Composition for reducing skin wrinkles including pde5 inhibitor |
| 01/31/2013 | US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | US20130030011 Compounds for the reduction of beta-amyloid production |
| 01/31/2013 | US20130030005 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors |
| 01/31/2013 | US20130029997 Pyrazinoisoquinoline compounds |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029994 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | US20130029993 Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors |
| 01/31/2013 | US20130029982 Heterocyclic compounds and uses thereof |
| 01/31/2013 | US20130029972 Notch pathway signaling inhibitor compound |
| 01/31/2013 | US20130029968 Indazoles |
| 01/31/2013 | US20130029967 Fused Imidazo [3,2 - D] Pyrazines as P13 Kinase Inhibitors |
| 01/31/2013 | US20130029964 [5, 6] heterocyclic compound |
| 01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
| 01/31/2013 | US20130029944 Inhibitors of protein kinases |
| 01/31/2013 | US20130029941 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors |
| 01/31/2013 | US20130028958 Beta-carbolines for use in the treatment of hearing loss and vertigo |
| 01/31/2013 | US20130026422 Bridged triarylamines and -phosphines as materials for electronic devices |
| 01/31/2013 | CA2843245A1 N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | CA2843109A1 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer |
| 01/31/2013 | CA2843022A1 Substituted quinolines and their use as medicaments |
| 01/31/2013 | CA2842976A1 Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/31/2013 | CA2842528A1 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators |
| 01/31/2013 | CA2841981A1 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 01/31/2013 | CA2841882A1 Indazoles |
| 01/30/2013 | EP2551269A1 Process for the preparation of varenicline |
| 01/30/2013 | EP2550271A1 Substituted pyridines having herbicidal action |
| 01/30/2013 | EP2550270A1 Substituted pyridazines having herbicidal action |
| 01/30/2013 | EP2550268A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550267A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550266A2 Heterocyclic compounds useful for kinase inhibition |
| 01/30/2013 | EP2550262A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | CN102906092A Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor |
| 01/30/2013 | CN102906090A 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy |
| 01/30/2013 | CN102906089A Compounds for the treatment of hepatitis C |
| 01/30/2013 | CN102906088A Substituted pyridazines having herbicidal action |
| 01/30/2013 | CN102906083A Novel substituted triazole derivatives as gamma secretase modulators |
| 01/30/2013 | CN102906074A Fused imidazole derivative |
| 01/30/2013 | CN102899032A Electropolymerizable fluorescent sensing material and application on fluorescent or electropolymerizable detection of metal ions |
| 01/30/2013 | CN102898480A Microwave-assisted synthesis method for ruthenium (II) arene compound |
| 01/30/2013 | CN102898427A Water-alcohol-soluble pyridinium salt based on small organic molecules, and preparation method and application thereof |
| 01/30/2013 | CN102898426A Pyrazolopyridine derivatives for inhibiting activity of insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase |
| 01/30/2013 | CN102898425A 4,5-glyoxalidine [1,2-a] quinoline derivative and application of 4,5- glyoxalidine [1,2-a] quinoline derivative |
| 01/30/2013 | CN102898371A Chiral polycyclic piperidine derivative, synthetic method and application |
| 01/30/2013 | CN102895844A Liquid carbon dioxide absorbent and preparation method thereof |
| 01/30/2013 | CN102267994B Preparation method of moxifloxacin hydrochloride known impurity |
| 01/30/2013 | CN102146080B Beta-carboline alkali derivative compounds and application thereof |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362251 Pyrrolo [3,2-C] pyridine-4-one 2-indolinone protein kinase inhibitors |
| 01/29/2013 | US8362249 CXCR3 receptor antagonists |
| 01/29/2013 | US8362237 Optical-isomer separating agent for chromatography and process for producing the same |
| 01/29/2013 | US8362030 Tricyclic derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 01/29/2013 | US8362020 Hepatitis C virus inhibitors |
| 01/29/2013 | US8362008 Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors |
| 01/29/2013 | CA2584179C N,n'-diphenylurea derivatives which are suitable as kinase inhibitors |
| 01/29/2013 | CA2578880C Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof |
| 01/24/2013 | WO2013012915A1 Heterocyclic compounds and uses thereof |
| 01/24/2013 | WO2013012844A1 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| 01/24/2013 | WO2013012829A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2013012827A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2013011932A1 Azabenzimidazole derivative having ampk-activating activity |
| 01/24/2013 | WO2013010880A1 New crth2 antagonists |
| 01/24/2013 | WO2013010453A1 Chemoking receptor antagonists |
| 01/24/2013 | US20130023660 Carboxamide Compounds and Methods for Using the Same |
| 01/24/2013 | US20130023554 5-phenylpyrazolopyridine derivatives, preparation and therapeutic use thereof |
| 01/24/2013 | US20130023537 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/24/2013 | US20130023532 Indazolyl-pyrimidines as kinase inhibitors |
| 01/24/2013 | US20130023531 Pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors |
| 01/24/2013 | US20130023525 Gyrase inhibitors and uses thereof |
| 01/24/2013 | US20130023518 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | CA2842187A1 Heterocyclic compounds and uses thereof |
| 01/24/2013 | CA2842103A1 Embodiments of a probe and method for targeting nucleic acids |
| 01/24/2013 | CA2841906A1 Azabenzimidazole derivative having ampk-activating activity |
| 01/23/2013 | EP2548876A1 New CRTh2 antagonists |
| 01/23/2013 | EP2548618A2 Organic compounds |
| 01/23/2013 | EP2548558A1 Nitrogen-containing condensed heterocyclic as inhibitors of bruton's tyrosine kinase |